N@N

VSI, ATHN, HYG, CQP, LUNA, ANGO Are Seasonally Ripe To Go Down In the Next Five Weeks

January 25, 2017 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net is monitoring the Seasonality of Vitamin Shoppe Inc. (NYSE:VSI), athenahealth, Inc. (NASDAQ:ATHN), iShares iBoxx $ High Yield Corporate Bond Fund (NYSE:HYG), Cheniere Energy Partners, LP (NYSE:CQP), Luna Innovations Incorporated (NASDAQ:LUNA), AngioDynamics Inc. (NASDAQ:ANGO) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. buyins.net is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:

The following stocks are expected to go Down:

  Symbol  Company                          Expected Return  Odds                 By The Following Date
  VSI     Vitamin Shoppe Inc.              -2.46%           100.00% (7 of 7)     Friday, January 27th 2017
  ATHN    athenahealth, Inc.               -3.06%           100.00% (9 of 9)     Monday, January 30th 2017
  HYG     iShares iBoxx $ High Yield Corporate Bond Fund  -0.74%           88.89% (8 of 9)      Wednesday, February 1st 2017
  CQP     Cheniere Energy Partners, LP     -3.58%           100.00% (9 of 9)     Wednesday, February 1st 2017
  LUNA    Luna Innovations Incorporated    -14.41%          90.00% (9 of 10)     Tuesday, March 7th 2017
  ANGO    AngioDynamics Inc.               -14.23%          100.00% (12 of 12)   Thursday, March 9th 2017

Vitamin Shoppe Inc. (NYSE:VSI) - Vitamin Shoppe, Inc., through its subsidiaries, operates as a multi-channel specialty retailer and contract manufacturer of nutritional products in the United States and internationally. It operates through three segments: Retail, Direct, and Manufacturing. The company provides custom manufacturing and private labeling services for VMS products, as well as develops and markets own branded products. It offers vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products of approximately 800 brands, including national brands comprising Optimum Nutrition, Cellucor, Garden of Life, Quest Nutrition, Solaray, Solgar, and Nature s Way; and own brands, such as Vitamin Shoppe, BodyTech, True Athlete, Mytrition, plnt, ProBioCare, Next Step, Nutri-Force Sport, and Betancourt Nutrition. The company sells its products through Vitamin Shoppe, Super Supplements, and Vitapath retail stores; and catalogs, as well as through its vitaminshoppe.com Website. As of December 7, 2016, it operated approximately 750 company-operated retail stores; and 5 franchise stores in Guatemala, 4 franchise stores in Panama, 3 franchise stores in Costa Rica, and 2 franchise stores in Paraguay. The company was formerly known as VS Holdings, Inc. and changed its name to Vitamin Shoppe, Inc. in November 2009. Vitamin Shoppe, Inc. was founded in 1977 and is headquartered in Secaucus, New Jersey..

athenahealth, Inc. (NASDAQ:ATHN) - athenahealth, Inc., together with its subsidiaries, provides cloud-based services and mobile applications for medical groups and health systems. The company provides services through athenaNet, a cloud-based platform. Its services include athenaCollector, a cloud-based revenue cycle management and practice management service; athenaClinicals for electronic health record management; athenaCommunicator, a cloud-based patient engagement and communication service; athenaCoordinator for order transmission; and athenaCoordinator Enterprise for care coordination, patient access, and order transmission service. The company also provides athenaCommunicator Enterprise, a cloud-based population health management service to execute, track, and coordinate care across a provider s network; and Epocrates service that include clinical information and decision support services in the areas of drug and disease information, medical calculator and tools, clinical guidelines, clinical messaging, market research, and formulary hosting. In addition, it offers client support, account performance monitoring, relationship management, and real-time performance monitoring services. The company serves clients in the health care industry that include pharmaceutical companies, managed care companies, market research firms, and others through its direct sales force and channel partners in the United States and internationally. The company was formerly known as athenahealth.com, Inc. and changed its name to athenahealth, Inc. in November 2000. athenahealth, Inc. was founded in 1997 and is headquartered in Watertown, Massachusetts..

iShares iBoxx $ High Yield Corporate Bond Fund (NYSE:HYG) - iShares iBoxx High Yield Corporate Bond Fund.

Cheniere Energy Partners, LP (NYSE:CQP) - Cheniere Energy Partners, L.P., through its subsidiary, Sabine Pass LNG, L.P., owns and operates regasification facilities at the Sabine Pass liquefied natural gas (LNG) terminal located on the Sabine-Neches Waterway. The company s regasification facilities include infrastructure of five LNG storage tanks with capacity of approximately 16.9 billion cubic feet equivalent; two docks that accommodate vessels of up to 266,000 cubic meters; and vaporizers with regasification capacity of approximately 4.0 billion cubic feet per day. It also owns the Creole Trail Pipeline, a 94-mile pipeline interconnecting the Sabine Pass LNG terminal with various interstate pipelines. Cheniere Energy Partners GP, LLC serves as the general partner of Cheniere Energy Partners, L.P. The company was founded in 2003 and is based in Houston, Texas. Cheniere Energy Partners, L.P. is subsidiary of Cheniere Energy, Inc..

Luna Innovations Incorporated (NASDAQ:LUNA) - Luna Innovations Incorporated develops, manufactures, and markets fiber optic sensing, and test and measurement products to measure, monitor, protect, and enhance processes in the aerospace, automotive, energy, composite, telecommunications, and defense industries worldwide. It operates in two segments, Products and Licensing, and Technology Development. The Products and Licensing segment offers fiber optic sensing, as well as test and measurement products to monitor the integrity of fiber optic network components and sub-assemblies, which include optical vector analyzer, optical backscatter reflectometers, and the Phoenix family of tunable lasers; and distributed sensing systems comprising optical distributed sensor interrogator sensing solution with multiple sensors whose inputs are integrated through a fiber optic network and software. This segment also packages optoelectronic semiconductors into high-speed optical receivers, custom optoelectronic subsystems, and Terahertz instrumentation products; licenses its technologies to third parties; and engages in the funded development of potential new products for corporate and government customers. The Technology Development segment provides applied research for customers in areas, such as nanomaterials, coatings, adhesives, composites, and bio-engineered materials; and sensors for the purpose of corrosion, temperature, strain, pressure, structural health, and chemical detection. The company sells its products to telecommunications companies, defense agencies, government system integrators, researchers, original equipment manufacturers, distributors, testing labs, and strategic partners directly, as well as through manufacturer representative organizations, partner and distribution channels, technical sales engineers, value added resellers, and independent sales representatives. Luna Innovations Incorporated was founded in 1990 and is headquartered in Roanoke, Virginia..

AngioDynamics Inc. (NASDAQ:ANGO) - AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices for vascular access, surgery, peripheral vascular disease, and oncology in the United States and internationally. The company provides manifolds, contrast management systems, closed fluid systems, guidewires, disposable transducers, and interventional accessories that help clinicians in the diagnosis and treatment of cardiovascular and peripheral vascular diseases; VenaCure EVLT laser system products to treat superficial venous diseases; Asclera drug for treating uncomplicated spider and reticular veins of the lower extremities; and Sotradecol drugs for treating small uncomplicated varicose veins of the lower extremities. It also offers AngioVac venous drainage system that includes venous drainage cannula for the removal of fresh, soft thrombi, or emboli during extracorporeal bypass; and cardiopulmonary bypass circuit for use in procedures during extracorporeal circulatory support. In addition, the company provides thrombolytic catheters to deliver thrombolytic agents; angiographic products and accessories for use in during peripheral vascular interventional procedures; drainage products, which drain abscesses and other fluid pockets; and micro access sets. Further, it offers peripherally inserted central catheters; ports that are implantable devices for the central venous administration; and dialysis products. Additionally, the company provides microwave ablation products; radiofrequency ablation products for ablating solid cancerous or benign tumors; and NanoKnife ablation systems for the surgical ablation of soft tissues. AngioDynamics, Inc. sells and markets its products to interventional radiologists, interventional cardiologists, vascular surgeons, urologists, and interventional and surgical oncologists directly, as well as through distributor relationships. The company was founded in 1988 and is headquartered in Latham, New York..

About BUYINS.NET

BUYINS.NET, http://www.buyins.net, monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS Friction Factor - Market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements" Naked Shorts (RegSho) - Tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING Earnings - Predicts probability, price move and length of move before and after all US stock earnings reports Seasonality - Predicts probability, price move and length of move based on exact time of year for all US stocks Group Correlation - Tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups SqueezeTrigger - Massive database that tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock. Valuation - Tracks all known valuation models and applies them. GATS - Tracks and quantifies known trading strategies by backtesting, optimizing and running genetic algorithms and neural networks to ascertain best trading strategies. PatternScan - Automates tracking of every technical pattern and predicts next move in stocks. Insider - Tracks insiders trading records and determines trading performance. Trades by higher-level insiders are generally more predictive than trades by lower level insiders Events - Tracks patterns directly correlated to specific events.

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. [symbol] has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.

Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net